Major limitations of this study include its focus on T cells and limited assessment of other subpopulations of immune cells, as well as analysis of ASPH inhibition combined with DNA vaccination in only one tumor model, which restricts the generalizability of the results. This evidence concerns the gene ASPH and neoplasm.